REGENXBIO (NASDAQ:RGNX) Price Target Cut to $12.00 by Analysts at The Goldman Sachs Group
REGENXBIO (NASDAQ:RGNX – Free Report) had its price objective decreased by The Goldman Sachs Group from $14.00 to $12.00 in a research report report published on Thursday morning,Benzinga reports. The Goldman Sachs Group currently has a neutral rating on the biotechnology company’s stock. RGNX has been the subject of several other research reports. HC Wainwright […]
REGENXBIO (NASDAQ:RGNX – Free Report) had its price objective decreased by The Goldman Sachs Group from $14.00 to $12.00 in a research report report published on Thursday morning,Benzinga reports. The Goldman Sachs Group currently has a neutral rating on the biotechnology company’s stock. RGNX has been the subject of several other research reports. HC Wainwright […]
